A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial

Author： Mercadante S.   Radbruch L.   Davies A.   Poulain P.   Sitte T.   Perkins P.   Colberg T.   Camba M.A.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.25, Iss.11, 2009-11, pp. : 2805-2815

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of intranasal fentanyl spray versus other opioids for breakthrough pain in cancer

By Vissers Debby   Stam Wiro   Nolte Thomas   Lenre Malin   Jansen Jeroen  

Current Medical Research and Opinion, Vol. 26, Iss. 5, 2010-05 ,pp. : 1037-1045

Informa Healthcare

Access to resources Recommend Favorite

Fentanyl buccal tablet in breakthrough cancer pain

By  

EUROPEAN JOURNAL OF PAIN (ELECTRONIC), Vol. 19, Iss. 4, 2015-04 ,pp. : 528-537

John Wiley & Sons Inc

Access to resources Recommend Favorite

A comparison of fentanyl with pethidine for pain relief during childbirth: a randomised controlled trial

By  

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 122, Iss. 7, 2015-06 ,pp. : 983-992

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fentanyl for Breakthrough Cancer Pain: Where are We?

By  

Reviews on Recent Clinical Trials, Vol. 8, Iss. 1, 2013-03 ,pp. : 42-47

Bentham Science Publishers

Access to resources Recommend Favorite

Patient Satisfaction with Fentanyl Sublingual Spray in Opioid‐Tolerant Patients with Breakthrough Cancer Pain

By  

PAIN PRACTICE, Vol. 15, Iss. 6, 2015-07 ,pp. : 554-563

John Wiley & Sons Inc

Access to resources Recommend Favorite